In Silico Methods for the Discovery of Orthosteric GABAB Receptor Compounds
Open Access
Abstract
The GABAB receptor (GABAB-R) is a heterodimeric class C G protein-coupled receptor comprised of the GABAB1a/b and GABAB2 subunits. The endogenous orthosteric agonist γ-amino-butyric acid (GABA) binds within the extracellular Venus flytrap (VFT) domain of the GABAB1a/b subunit. The receptor is associated with numerous neurological and neuropsychiatric disorders including learning and memory deficits, depression and anxiety, addiction and epilepsy, and is an interesting target for new drug development. Ligand- and structure-based virtual screening (VS) are used to identify hits in preclinical drug discovery. In the present study, we have evaluated classical ligand-based in silico methods, fingerprinting and pharmacophore mapping and structure-based in silico methods, structure-based pharmacophores, docking and scoring, and linear interaction approximation (LIA) for their aptitude to identify orthosteric GABAB-R compounds. Our results show that the limited number of active compounds and their high structural similarity complicate the use of ligand-based methods. However, by combining ligand-based methods with different structure-based methods active compounds were identified in front of DUDE-E decoys and the number of false positives was reduced, indicating that novel orthosteric GABAB-R compounds may be identified by a combination of ligand-based and structure-based in silico methods.Keywords
Funding Information
- Polish-Norwegian Research Program (Pol-Nor/198887/73/2013)
- HelseNord (HNF1426-18)
- Polish National Centre for Reserach and development (LIDER/37/0137/L-9/17/NCBR/2018)
This publication has 56 references indexed in Scilit:
- Enhanced ranking of PknB Inhibitors using data fusion methodsJournal of Cheminformatics, 2013
- Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better BenchmarkingJournal of Medicinal Chemistry, 2012
- The GABABreceptor as a target for antidepressant drug actionBritish Journal of Pharmacology, 2010
- Flexible ligand docking to multiple receptor conformations: a practical alternativeCurrent Opinion in Structural Biology, 2008
- Benchmarking Sets for Molecular DockingJournal of Medicinal Chemistry, 2006
- Structure-based Drug Discovery Using GPCR Homology Modeling: Successful Virtual Screening for Antagonists of the Alpha1A Adrenergic ReceptorJournal of Medicinal Chemistry, 2005
- GABA-ergic hypotheses of anxiety and depression: Focus on GABA-B receptorDrugs of Today, 2005
- Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptorsNature, 1997
- The Importance of Stereochemistry in Drug Action and DispositionThe Journal of Clinical Pharmacology, 1992
- Evaluation of baclofen (Lioresal) for spasticity in multiple sclerosisPostgraduate Medical Journal, 1975